Abstract:Bladder cancer is currently considered the most common malignancy of the urinary tract. Thulium laser en bloc resection of bladder tumor (TmLRBT) and plasmakinetic transurethral resection of bladder tumor (PK-TURBT) are two alternative common procedures used in our department to manage patients with primary non-muscle invasive bladder cancer (NMIBC) over the past decade. In this work, the safety and efficacy of TmLRBT were retrospectively compared to those of PK-TURBT in patients with primary NMIBC. From January 2013 to December 2015, 256 patients diagnosed with primary NMIBC were selected for this retrospective study. A total of 136 consecutive patients diagnosed with primary NMIBC were enrolled in the TmLRBT group. A similar historical cohort of 120 consecutive patients who underwent PK-TURBT was used to compare the two procedures. Clinical data, including age, gender, tumor characteristics, operation duration, hospitalization, irrigation, catheterization, and intraoperative and postoperative complications, were recorded. There were no significant differences in age, gender, mean tumor size, mean tumor number, tumor location, or risk between the TmLRBT and PK-TURBT groups. The TmLRBT group was associated with a significantly shorter operation duration (25.96 ± 21.19 min vs 37.18 ± 25.77 min, P = 0.018) and a shorter hospitalization time (3.11 ± 1.05 days vs 5.24 ± 2.06 days, P = 0.036). The postoperative irrigation time (6.33 ± 4.05 h vs 14.76 ± 6.28 h, P = 0.027) and catheterization time (2.03 ± 1.61 days vs 4.27 ± 1.17 days, P = 0.035) in the TmLRBT group were lower than those in the PK-TURBT group. No significant differences in fever and rebleeding were found in the TmLRBT and PK-TURBT groups. There were no significant differences in the overall, low-risk, intermediate-risk, and high-risk recurrence-free rates between the two groups ( P = 0.43, P = 0.68, P = 0.71, and P = 0.24, respectively). The proportion of bladder detrusor muscle (BDM) identified in pathologic specimens of the TmLRBT group was higher than that in the PK-TURBT group ( P = 0.006). TmLRBT may reduce operation duration time, hospitalization time, postoperative irrigation time, and catheterization time. TmLRBT is considered safer and more effective in treating primary NMIBC. Recurrence-free rates did not differ between groups.

Safety and efficacy of 120W high performance system greenlight laser vaporization for non-muscle-invasive bladder cancer.

Efficacy and Safety of Potassium-Titanyl- Phosphate Laser Vaporization for Clinically Non-Muscle Invasive Bladder Cancer.

The Application of 120-W High-Performance System GreenLight Laser Vaporization of the Prostate in High-Risk Patients

Evaluation of 80-W and 120-W GreenLight Laser Vaporization for Benign Prostatic Hyperplasia in High-Risk Patients

Randomized controlled study of photoselective en bloc transurethral resection of non-muscle invasive bladder tumor with green laser

GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a prospective randomized trial.

Potassium-titanyl-phosphate Laser Vaporization in the Treatment of Superficial Bladder Tumor

Green Laser Vaporization in The Treatment of Superficial Bladder Tumor and Biopsy of The Surgical Basement

Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer.

Comparison of Techniques and Perioperative Complications of the 120 W Greenlight HPS Laser and the 80 W KTP Laser for Photoselective Vaporization of the Prostate

The clinical study of en bloc transurethral resection with 980 nm laser for treatment of primary non -muscle invasive bladder cancer

Comparison of Vaporization Using 120-W GreenLight Laser Versus 2-Micrometer Continuous Laser for Treating Benign Prostatic Hyperplasia: A 24-Month Follow-Up Study of a Single Center

KTP Green Laser Vaporization of Biologic Tissue under Water and Its Clinical Application.

A comparison of incidences of bladder neck contracture of 80- versus 180-W GreenLight laser photoselective vaporization of benign prostatic hyperplasia

Safety and Efficacy of Holmium Laser Resection for Primary Nonmuscle-Invasive Bladder Cancer Versus Transurethral Electroresection: Single-center Experience

Photoselective potassium-titanyl-phosphate laser vaporization prostatectomy for the treatment of high-risk patients with benign prostatic hyperplasia

A retrospective comparison of thulium laser en bloc resection of bladder tumor and plasmakinetic transurethral resection of bladder tumor in primary non-muscle invasive bladder cancer

Novel transurethral laser surgery versus conventional TURBT for treating non-mus-cle invasive bladder cancer:a systematic review and met a-analysis

A Randomized Controlled Trial on Holmium Laser Resection and Plasmakinetic Resection of Bladder Tumors

Novel Green-Light KTP Laser En Bloc Enucleation for Nonmuscle-Invasive Bladder Cancer: Technique and Initial Clinical Experience.

Experience of treating high risk prostate hyperplasia patients with a HPS120 laser